As pharmaceutical companies increasingly rely on artificial intelligence (AI) to optimise trial processes, the potential for AI models to drift over time poses significant risks to trial integrity ...
According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated Disclosure UK system operated by the Association of the British ...